Figure 1
From: Pricing and reimbursement of orphan drugs: the need for more transparency

Association between annual Belgian cost per patient of an orphan drug and disease prevalence.
From: Pricing and reimbursement of orphan drugs: the need for more transparency
Association between annual Belgian cost per patient of an orphan drug and disease prevalence.